Warfarin in idiopathic pulmonary fibrosis: friend or foe, is it a matter of genes and heparin?

Joachim Müller-Quernheim, Athol Wells, None, Evidence-based recommendations in idiopathic pulmonary fibrosis: a year is a long time in interstitial lung disease. American Journal of Respiratory and Critical Care Medicine. ,vol. 186, pp. 5- 7 ,(2012) , 10.1164/RCCM.201205-0883ED

Scott C. Litin, Dennis A. Gastineau, Current Concepts in Anticoagulant Therapy Mayo Clinic Proceedings. ,vol. 70, pp. 266- 272 ,(1995) , 10.4065/70.3.266

Hiroshi Kubo, Katsutoshi Nakayama, Masaru Yanai, Tomoko Suzuki, Mutsuo Yamaya, Mika Watanabe, Hidetada Sasaki, Anticoagulant Therapy for Idiopathic Pulmonary Fibrosis Chest. ,vol. 128, pp. 1475- 1482 ,(2005) , 10.1378/CHEST.128.3.1475

Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao De Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman, None, A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis American Journal of Respiratory and Critical Care Medicine. ,vol. 186, pp. 88- 95 ,(2012) , 10.1164/RCCM.201202-0314OC

Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg, Dominique Valeyre, Roland M du Bois, Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. The Lancet. ,vol. 377, pp. 1760- 1769 ,(2011) , 10.1016/S0140-6736(11)60405-4

Carville Bevans, Andreas Fregin, Christof Geisen, Clemens Müller-Reible, Matthias Watzka, Johannes Oldenburg, Current pharmacogenetic developments in oral anticoagulation therapy: The influence of variant VKORC1 and CYP2C9 alleles Thrombosis and Haemostasis. ,vol. 98, pp. 570- 578 ,(2007) , 10.1160/TH07-07-0454

, Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis The New England Journal of Medicine. ,vol. 366, pp. 1968- 1977 ,(2012) , 10.1056/NEJMOA1113354

Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu, Michèle Brun, Abhya Gupta, Nolwenn Juhel, Matthias Klüglich, Roland M du Bois, None, Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. The New England Journal of Medicine. ,vol. 365, pp. 1079- 1087 ,(2011) , 10.1056/NEJMOA1103690

Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky, David A Lynch, Jay H Ryu, Jeffrey J Swigris, Athol U Wells, Julio Ancochea, Demosthenes Bouros, Carlos Carvalho, Ulrich Costabel, Masahito Ebina, David M Hansell, Takeshi Johkoh, Dong Soon Kim, Talmadge E King Jr, Yasuhiro Kondoh, Jeffrey Myers, Nestor L Muller, Andrew G Nicholson, Luca Richeldi, Moisés Selman, Rosalind F Dudden, Barbara S Griss, Shandra L Protzko, Holger J Schunemann, None, An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management American Journal of Respiratory and Critical Care Medicine. ,vol. 183, pp. 788- 824 ,(2011) , 10.1164/RCCM.2009-040GL